Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000291116 | SCV000345357 | pathogenic | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365327 | SCV002664847 | pathogenic | Familial thoracic aortic aneurysm and aortic dissection | 2018-09-21 | criteria provided, single submitter | clinical testing | The c.6682dupT pathogenic mutation, located in coding exon 54 of the FBN1 gene, results from a duplication of T at nucleotide position 6682, causing a translational frameshift with a predicted alternate stop codon (p.Y2228Lfs*2). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |